Promising brain cancer imaging study halted after just one patient
NCT ID NCT05222269
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This study aimed to see if a special PET scan using a tracer called PentixaFor could predict how well brain lymphoma patients would respond to chemotherapy. Only one person enrolled before the study was stopped early. The goal was to see if a negative scan after a few weeks of treatment meant a better chance of staying cancer-free for a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CNS LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Aalborg
Aalborg, 9000, Denmark
-
University Hospital CHU Nantes
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.